A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results for " Letermovir "

media.product.imagealternatetextformat.details

Letermovir d8

N° de SZ CAT:SZ-L052D02
Número CAS1961287-35-3
Mol.F.C29H20D8F4N4O4
Peso Molecular580.6
Status de FaturaCustom Synthesis

Nome Químico: 2-[(4S)-8-Fluoro-2-[4-(3-methoxyphenyl)piperazin D8-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl] -4H-quinazolin-4-yl]acetic acid

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

Sorrisos: O=C(O)C[C@@H]1N(C2=CC(C(F)(F)F)=CC=C2OC)C(N3C([2H])([2H])C([2H])([2H])N(C4=CC=CC(OC)=C4)C([2H])([2H])C3([2H])[2H])=NC5=C1C=CC=C5F

Letermovir d8 is chemically 2-[(4S)-8-Fluoro-2-[4-(3-methoxyphenyl)piperazin D8-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl] -4H-quinazolin-4-yl]acetic acid. Letermovir d8 is supplied with detailed characterization data compliant with regulatory guideline. Letermovir d8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Letermovir.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.